BDBM66264 3-[4-(3,5-dimethyl-1-piperidinyl)-4-oxobutyl]-2-sulfanylidene-1H-quinazolin-4-one::3-[4-(3,5-dimethylpiperidin-1-yl)-4-oxidanylidene-butyl]-2-sulfanylidene-1H-quinazolin-4-one::3-[4-(3,5-dimethylpiperidin-1-yl)-4-oxobutyl]-2-sulfanylidene-1H-quinazolin-4-one::3-[4-(3,5-dimethylpiperidin-1-yl)-4-oxobutyl]-2-thioxo-2,3-dihydroquinazolin-4(1H)-one::3-[4-(3,5-dimethylpiperidino)-4-keto-butyl]-2-thioxo-1H-quinazolin-4-one::MLS000095296::SMR000030850::cid_3242348

SMILES CC1CC(C)CN(C1)C(=O)CCCn1c(=S)[nH]c2ccccc2c1=O

InChI Key InChIKey=OKVHEWLZUHCTRI-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 66264   

TargetTransient receptor potential cation channel subfamily M member 3(Mouse)
Katholieke Universiteit Leuven

US Patent
LigandChemical structure of BindingDB Monomer ID 66264BDBM66264(US12209081, Compound 435-En-2)
Affinity DataIC50: 1.00E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute (TS...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2026
Entry Details US Patent